Tarsus Pharmaceuticals Inc Ordinary Shares (NASDAQ:TARS)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - TARS
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - TARS
- Market Cap$827.450m
- SymbolNASDAQ:TARS
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS87650L1035
Company Profile
Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites.
Latest TARS news
Currently there for this company. Visit our news hub for other news .